NovaBay Pharmaceuticals Inc (AMEX:NBY)
$ 0.7497 0.0097 (1.31%) Market Cap: 3.67 Mil Enterprise Value: 4.88 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 42/100

NovaBay Pharmaceuticals Inc at OTC Markets Life Sciences Investor Forum Transcript

Sep 15, 2022 / 05:00PM GMT
Release Date Price: $181.55 (-5.06%)
Bob Power
OTC Markets Group - SVP

Hello, and welcome to virtual investor conferences. My name is Bob Power, and on behalf of OTC markets, we're very pleased you have joined us for our next slide presentation from NovaBay Pharmaceuticals.

Before I introduce our speakers, a few points to note. (Operator instructions) On a final note, all of today's presentations will be recorded and available for 24/7 replay.

At this point, I'm very pleased to welcome Justin Hall, Chief Executive Officer; and Andrew Jones, Chief Financial Officer, of NovaBay Pharmaceuticals, which trades on the NYSE American under the symbol NBY.

Welcome, Justin and Andrew.

Justin Hall
NovaBay Pharmaceuticals, Inc. - CEO

Thanks, Bob.

Andrew Jones
NovaBay Pharmaceuticals, Inc. - CFO

Hi.

Justin Hall
NovaBay Pharmaceuticals, Inc. - CEO

And thanks, everybody, for joining us. We have a lot of exciting things happening here at NovaBay, and very pleased to be sharing it with

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot